DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was downgraded by equities researchers at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Wednesday.

XRAY has been the topic of a number of other research reports. Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday. Credit Suisse Group reiterated an “outperform” rating and set a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. UBS AG restated a “neutral” rating and set a $59.00 price objective (down previously from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Stifel Nicolaus restated a “buy” rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Finally, Goldman Sachs Group, Inc. (The) lowered DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $66.25.

Shares of DENTSPLY SIRONA (XRAY) traded down 0.80% on Wednesday, reaching $53.33. The company’s stock had a trading volume of 442,682 shares. The firm’s market cap is $12.24 billion. DENTSPLY SIRONA has a 1-year low of $53.22 and a 1-year high of $65.68. The company’s 50 day moving average is $62.34 and its 200-day moving average is $62.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.65. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.76 earnings per share. Equities research analysts expect that DENTSPLY SIRONA will post $2.72 EPS for the current year.

WARNING: “DENTSPLY SIRONA Inc. (XRAY) Lowered to Strong Sell at BidaskClub” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/16/dentsply-sirona-inc-xray-lowered-to-strong-sell-at-bidaskclub.html.

Large investors have recently modified their holdings of the stock. Capital Fund Management S.A. acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $1,941,000. Security National Bank of SO Dak increased its stake in shares of DENTSPLY SIRONA by 3.1% in the fourth quarter. Security National Bank of SO Dak now owns 17,336 shares of the medical instruments supplier’s stock worth $1,055,000 after buying an additional 525 shares in the last quarter. First Quadrant L P CA acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $17,567,000. Nordea Investment Management AB increased its stake in shares of DENTSPLY SIRONA by 17.4% in the fourth quarter. Nordea Investment Management AB now owns 32,713 shares of the medical instruments supplier’s stock worth $1,991,000 after buying an additional 4,847 shares in the last quarter. Finally, Trillium Asset Management LLC increased its stake in shares of DENTSPLY SIRONA by 2.7% in the fourth quarter. Trillium Asset Management LLC now owns 135,448 shares of the medical instruments supplier’s stock worth $8,242,000 after buying an additional 3,523 shares in the last quarter. 95.13% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.